Characterization of Virulence Factors in Candida Species Causing Candidemia in a Tertiary Care Hospital in Bangkok, Thailand
暂无分享,去创建一个
N. Chantratita | P. Sukphopetch | T. Wongsuk | N. Saiprom | Siriphan Boonsilp | W. Oonanant | Worrapoj Oonanant | Natnaree Saiprom
[1] S. Paul,et al. Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis , 2022, PloS one.
[2] T. Wongsuk,et al. Species Distribution, Antifungal Susceptibility, and Molecular Epidemiology of Candida Species Causing Candidemia in a Tertiary Care Hospital in Bangkok, Thailand , 2021, Journal of fungi.
[3] M. Chayakulkeeree,et al. Risk Factors and Outcomes of Non-albicans Candida Bloodstream Infection in Patients with Candidemia at Siriraj Hospital—Thailand’s Largest National Tertiary Referral Hospital , 2021, Journal of fungi.
[4] K. Zomorodian,et al. High detection of virulence factors by Candida species isolated from bloodstream of patients with candidemia. , 2020, Microbial pathogenesis.
[5] T. West,et al. Genomic loss in environmental and isogenic morphotype isolates of Burkholderia pseudomallei is associated with intracellular survival and plaque-forming efficiency , 2020, PLoS neglected tropical diseases.
[6] P. Chongtrakool,et al. An Association of an eBURST Group With Triazole Resistance of Candida tropicalis Blood Isolates , 2020, Frontiers in Microbiology.
[7] Duncan W. Wilson,et al. Cooperative Role of MAPK Pathways in the Interaction of Candida albicans with the Host Epithelium , 2019, Microorganisms.
[8] A. Kummasook,et al. Anti-fungal susceptibility and virulence factors of Candida spp. isolated from blood cultures. , 2019, Journal de mycologie medicale.
[9] N. Soliman,et al. Prevalence of Candida blood stream infections among children in tertiary care hospital: detection of species and antifungal susceptibility , 2019, Infection and drug resistance.
[10] S. Paul,et al. Extensive ERG11 mutations associated with fluconazole-resistant Candida albicans isolated from HIV-infected patients , 2019, Current medical mycology.
[11] J. Jayaweera,et al. The emergence of non-albicans candidemia and evaluation of HiChrome Candida differential agar and VITEK2 YST® platform for differentiation of Candida bloodstream isolates in teaching hospital Kandy, Sri Lanka , 2019, BMC Microbiology.
[12] J. Jayaweera,et al. The emergence of non-albicans candidemia and evaluation of HiChrome Candida differential agar and VITEK2 YST® platform for differentiation of Candida bloodstream isolates in teaching hospital Kandy, Sri Lanka , 2019, BMC Microbiology.
[13] Y. An,et al. Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China , 2019, Antimicrobial resistance and infection control.
[14] L. C. D. Souza,et al. Virulence factors of Candida spp. obtained from blood cultures of patients with candidemia attended at tertiary hospitals in Northeast Brazil. , 2019, Journal de mycologie medicale.
[15] M. Shams-Ghahfarokhi,et al. Comparative analysis of proteinase, phospholipase, hydrophobicity and biofilm forming ability in Candida species isolated from clinical specimens. , 2018, Journal de mycologie medicale.
[16] Z. Dagher,et al. Fluorescent Tracking of Yeast Division Clarifies the Essential Role of Spleen Tyrosine Kinase in the Intracellular Control of Candida glabrata in Macrophages , 2018, Front. Immunol..
[17] Qi Wang,et al. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates , 2018, BMC Infectious Diseases.
[18] Miguel C. Teixeira,et al. Candida Biofilms: Threats, Challenges, and Promising Strategies , 2018, Front. Med..
[19] M. E. S. Ferreira,et al. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil , 2018, Mycoses.
[20] G. M. Chaves,et al. An Update on Candida tropicalis Based on Basic and Clinical Approaches , 2017, Front. Microbiol..
[21] A. Ayadi,et al. Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens , 2017, Journal of Biomedical Science.
[22] J. Teo,et al. ERG11 mutations are associated with high-level azole resistance in clinical Candida tropicalis isolates, a Singapore study , 2017 .
[23] E. Berkow,et al. Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species , 2017, Frontiers in microbiology.
[24] M. Kaur,et al. Studying the Prevalence, Species Distribution, and Detection of In vitro Production of Phospholipase from Candida Isolated from Cases of Invasive Candidiasis , 2017, Journal of global infectious diseases.
[25] Zhixin Liang,et al. Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes , 2016, Mycopathologia.
[26] A. Marra,et al. Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program , 2016, PloS one.
[27] E. Berk,et al. Investigation of the relationship between virulence factors and genotype of Candida spp. isolated from blood cultures. , 2015, Journal of infection in developing countries.
[28] Wei Liu,et al. The A395T Mutation in ERG11 Gene Confers Fluconazole Resistance in Candida tropicalis Causing Candidemia , 2015, Mycopathologia.
[29] A. Rodrigues,et al. Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp. , 2015, Front. Microbiol..
[30] D. Moyes,et al. Candida albicans-epithelial interactions and pathogenicity mechanisms: scratching the surface , 2015, Virulence.
[31] M. C. Furlaneto,et al. Effects of human blood red cells on the haemolytic capability of clinical isolates of Candida tropicalis , 2015, Journal of Biomedical Science.
[32] P. Chong,et al. Candida albicans isolates from a Malaysian hospital exhibit more potent phospholipase and haemolysin activities than non-albicans Candida isolates. , 2013, Tropical biomedicine.
[33] M. Blanco-Blanco,et al. Determination of biofilm production by Candida tropicalis isolated from hospitalized patients and its relation to cellular surface hydrophobicity, plastic adherence and filamentation ability , 2013, Yeast.
[34] E. Ortega,et al. Aminopeptidase N (CD13) Is Involved in Phagocytic Processes in Human Dendritic Cells and Macrophages , 2013, BioMed research international.
[35] Jingyi Zhang,et al. In vitro fluconazole susceptibility of 1,903 clinical isolates of Candida albicans and the identification of ERG11 mutations. , 2013, Microbial drug resistance.
[36] J. Grimalt,et al. Candida tropicalis Antifungal Cross-Resistance Is Related to Different Azole Target (Erg11p) Modifications , 2013, Antimicrobial Agents and Chemotherapy.
[37] S. H. Alves,et al. Determination of germ tube, phospholipase, and proteinase production by bloodstream isolates of Candida albicans. , 2013, Revista da Sociedade Brasileira de Medicina Tropical.
[38] Beiqin Yu,et al. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. , 2013, The Journal of antimicrobial chemotherapy.
[39] D. Horn,et al. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008. , 2012, Diagnostic microbiology and infectious disease.
[40] Rosário Oliveira,et al. Insights into Candida tropicalis nosocomial infections and virulence factors , 2012, European Journal of Clinical Microbiology & Infectious Diseases.
[41] M. Schaller,et al. Candida albicans-Epithelial Interactions: Dissecting the Roles of Active Penetration, Induced Endocytosis and Host Factors on the Infection Process , 2012, PloS one.
[42] C. D. de Koster,et al. Hyphal induction in the human fungal pathogen Candida albicans reveals a characteristic wall protein profile. , 2011, Microbiology.
[43] K. Ng,et al. Proteinase, phospholipase, biofilm forming abilities and antifungal susceptibilities of Malaysian Candida isolates from blood cultures. , 2011, Medical mycology.
[44] Rosário Oliveira,et al. The role of secreted aspartyl proteinases in Candida tropicalis invasion and damage of oral mucosa. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[45] C. Tsang,et al. HIV protease inhibitors differentially inhibit adhesion of Candida albicans to acrylic surfaces , 2010, Mycoses.
[46] P. Le Pape,et al. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. , 2010, Diagnostic microbiology and infectious disease.
[47] N. Bannert,et al. Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes , 2010, Cellular microbiology.
[48] David W Williams,et al. Characterization of Candida parapsilosis infection of an in vitro reconstituted human oral epithelium. , 2009, European Journal of Oral Sciences.
[49] C. D. de Koster,et al. Of Novel Adhesin-like Wall Proteins : Differential Incorporation Candida Glabrata Supplemental Material , 2008 .
[50] David F. Smith,et al. Glycan microarray analysis of Candida glabrata adhesin ligand specificity , 2008, Molecular microbiology.
[51] W. Leung,et al. Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. , 2007, Journal of medical microbiology.
[52] C. Silveira,et al. Enzymatic and hemolytic activities of Candida dubliniensis strains. , 2007, Revista do Instituto de Medicina Tropical de Sao Paulo.
[53] M. Whiteway,et al. Proteomic analysis of Candida albicans yeast and hyphal cell wall and associated proteins , 2006, Proteomics.
[54] M. Schaller,et al. Hydrolytic enzymes as virulence factors of Candida albicans , 2005, Mycoses.
[55] D. Underhill,et al. Dectin‐1 mediates macrophage recognition of Candida albicans yeast but not filaments , 2005, The EMBO journal.
[56] A. Fluit,et al. High levels of hydrolytic enzymes secreted by Candida albicans isolates involved in respiratory infections. , 2003, Journal of medical microbiology.
[57] S. Challacombe,et al. Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis , 2003, Microbiology and Molecular Biology Reviews.
[58] P. Chiani,et al. Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects. , 2002, The Journal of infectious diseases.
[59] B. Wickes,et al. Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicansBiofilms , 2001, Antimicrobial Agents and Chemotherapy.
[60] L. Samaranayake,et al. Candida Species Exhibit Differential In Vitro Hemolytic Activities , 2001, Journal of Clinical Microbiology.
[61] M. Dierich,et al. HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro. , 2001, FEMS immunology and medical microbiology.
[62] L. Samaranayake,et al. Adhesion of Candida parapsilosis to epithelial and acrylic surfaces correlates with cell surface hydrophobicity , 2001, Mycoses.
[63] M. Ghannoum. Potential Role of Phospholipases in Virulence and Fungal Pathogenesis , 2000, Clinical Microbiology Reviews.
[64] A. Telenti,et al. HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. , 1999, The Journal of investigative dermatology.
[65] E. Tacconelli,et al. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. , 1999, The Journal of infectious diseases.
[66] E. Tacconelli,et al. Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study. , 1999, Journal of acquired immune deficiency syndromes.
[67] A. Pachì,et al. High Aspartyl Proteinase Production and Vaginitis in Human Immunodeficiency Virus-Infected Women , 1999, Journal of Clinical Microbiology.
[68] A. Chakrabarti,et al. In vitro proteinase production by Candida species , 1991, Mycopathologia.
[69] J. Zajic,et al. Factors governing adherence of Candida species to plastic surfaces , 1985, Infection and immunity.
[70] M. Rosenberg. Bacterial adherence to hydrocarbons: a useful technique for studying cell surface hydrophobicity , 1984 .
[71] Shigeru Tsuchiya,et al. Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1) , 1980, International journal of cancer.
[72] B. Kullberg,et al. Invasive Candidiasis. , 2015, The New England journal of medicine.
[73] C. Sachin,et al. In vitro evaluation of proteinase, phospholipase and haemolysin activities of Candida species isolated from clinical specimens , 2012 .
[74] M. Netea,et al. An integrated model of the recognition of Candida albicans by the innate immune system , 2008, Nature Reviews Microbiology.